Media headlines about Neptune Technologies & Bioressources (NASDAQ:NEPT) (TSE:NTB) have been trending somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Neptune Technologies & Bioressources earned a news impact score of 0.24 on Accern’s scale. Accern also gave media coverage about the biotechnology company an impact score of 45.4437104058158 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Shares of Neptune Technologies & Bioressources (NEPT) traded down $0.20 during midday trading on Friday, reaching $3.07. 1,239,799 shares of the company’s stock traded hands, compared to its average volume of 902,944. Neptune Technologies & Bioressources has a twelve month low of $0.70 and a twelve month high of $3.30. The firm has a market cap of $257.20, a PE ratio of 38.38 and a beta of 1.12.
WARNING: This article was reported by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.com-unik.info/2018/01/13/neptune-technologies-bioressources-nept-receiving-somewhat-positive-news-coverage-analysis-finds.html.
Neptune Technologies & Bioressources Company Profile
Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.
Receive News & Ratings for Neptune Technologies & Bioressources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources and related companies with MarketBeat.com's FREE daily email newsletter.